188 related articles for article (PubMed ID: 35763632)
1. Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran.
Makvandi M; Noormandi Pour S; Teimoori A; Shokri S; Mahmoudvand S; Biparva Haghighi S; Rajaee E
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1921-1926. PubMed ID: 35763632
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment.
Mahmoudvand S; Shokri S; Mirzaei H; Ramazani A; Makvandi M; Neisi N; Hashemi SJ
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2939-2944. PubMed ID: 34582665
[TBL] [Abstract][Full Text] [Related]
3. Occult Hepatitis B Virus Infection among β-Thalassemia Major Patients in Ahvaz City, Iran.
Amirhashchi F; Azaran A; Seyedian SS; Jalilian S; Keikhaei B
Am J Trop Med Hyg; 2021 Oct; 106(1):174-181. PubMed ID: 34607305
[TBL] [Abstract][Full Text] [Related]
4. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.
Elkady A; Aboulfotuh S; Ali EM; Sayed D; Abdel-Aziz NM; Ali AM; Murakami S; Iijima S; Tanaka Y
World J Gastroenterol; 2013 Oct; 19(37):6214-20. PubMed ID: 24115819
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.
Watanabe R; Ishii T; Nakamura K; Shirai T; Tajima Y; Fujii H; Harigae H
Mod Rheumatol; 2013 Nov; 23(6):1094-100. PubMed ID: 23180323
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Overt and Occult Hepatitis B Virus Infection among HIV-Positive People Referring to Consultation Center for Behavioral Diseases, Kurdistan Province, Iran.
Azmoudeh-Ardalan F; Khodabandehloo M
Iran Biomed J; 2021 Nov; 25(6):434-40. PubMed ID: 34717309
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran.
Taherkhani R; Farshadpour F
PLoS One; 2022; 17(3):e0265063. PubMed ID: 35271684
[TBL] [Abstract][Full Text] [Related]
12. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
Laohapand C; Arromdee E; Tanwandee T
Hepatol Int; 2015 Apr; 9(2):202-8. PubMed ID: 25788188
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia.
Bubonja-Šonje M; Peruč D; Abram M; Mohar-Vitezić B
Ann Hepatol; 2024; 29(1):101156. PubMed ID: 37758118
[TBL] [Abstract][Full Text] [Related]
16. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
Chenari M; Norouzi M; Ghalichi L; Rezaee A; Yari A; Alavian SM; Jazayeri SM
J Med Virol; 2014 Nov; 86(11):1861-7. PubMed ID: 25132488
[TBL] [Abstract][Full Text] [Related]
17. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
[TBL] [Abstract][Full Text] [Related]
18. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
20. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
